The veterinary vaccines market comprises various vaccine types such as live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, recombinant vaccines, and others that are used for preventing infections in livestock and companion animals. The administration of vaccines enhances the immunity and disease resistance levels of animals. The increasing incidence rate of zoonotic diseases, rising demand for animal food products, investment in R&D for new vaccine formulations, and surging companion animal ownership are some of the key drivers of the veterinary vaccines market.

The veterinary vaccines market is estimated to be valued at USD 9.70 Bn in 2024 and is expected to reach USD 16.17 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.

Key Takeaways
Key players operating in the veterinary vaccines market are Zoetis Inc., Merck and Co. Inc., Boehringer Ingelheim GmbH., Eli Lilly and Company, Veteraquimica SA, and Hester Biosciences Limited. These players are investing heavily in R&D activities to develop advanced vaccine formulations.

The Veterinary Vaccine Market Forecast provides significant opportunities for vaccines targeting emerging and re-emerging pathogens. Advancements in vaccine applications such as thermostability, single-dose formulations, and needle-free administration methods are attracting more veterinarians and pet owners.

Continuous technological advancements are helping vaccine developers in designing efficient, safer, and thermostable vaccines. Recombinant DNA technology, reverse genetics technique, and adjuvants are enabling the development of new generation veterinary vaccines with enhanced immunogenicity and stability.

Market Drivers
Growing consumption of animal-derived food products such as meat and seafood is propelling the demand for veterinary vaccines globally. According to FAO, the worldwide meat production is projected to increase by over 1.5 times by 2050 to meet the requirement of the growing population. This will increase the risk of disease outbreaks requiring effective immunization of livestock.

Rising occurrences of zoonotic diseases that can transmit from animals to humans, such as rabies, leptospirosis, and anthrax, are driving vaccine administration among pets and livestock. Surging adoption of companion animals and increased awareness regarding pet health and preventive healthcare is boosting the veterinary vaccines sales considerably.

Current Challenges in Veterinary Vaccines Market
The Veterinary Vaccines Market Size and Trends is facing multiple challenges such as lack of awareness about animal healthcare, high cost of vaccine development, and lack of infrastructure and skilled professionals in many regions. Proper vaccination is necessary to prevent spread of infectious diseases among animals. However, inadequate access to veterinary facilities and lack of trained animal healthcare professionals have hindered effective vaccination drives in developing nations. Moreover, developing new vaccines requires extensive R&D and clinical trials, pushing up production costs. This makes vaccines unaffordable for large animal populations in low-income countries. Addressing these challenges would help boost vaccination rates and curb diseases.

SWOT Analysis
Strength: Wide range of vaccines available for major livestock and companion animal diseases. Rapid advancements in veterinary vaccine technologies.

Weakness: High R&D costs associated with new vaccine development. Low affordability of vaccines in developing regions due to insufficient public healthcare funding.

Opportunity: Rising pet ownership and growing demand for animal-derived food products to drive vaccine usage. Scope for improving prevention efforts against zoonotic diseases through cross-sectoral collaborations.

Threats: Threat of new infectious diseases emerging and evolving. stringent regulations delays vaccine approvals.

Geographically, North America dominates the veterinary vaccines market, accounting for over 35% revenue share in 2024. This is attributed to growing pet care expenditure, availability of advanced veterinary healthcare facilities, and presence of major market players in the region. On the other hand, Asia Pacific exhibits the fastest growth and is estimated to expand at a CAGR of around 9% during the forecast period. Rising livestock farming in India and China along with increasing animal disease awareness will drive the APAC market.

The US market holds the highest value currently due to large livestock population and policy support for animal welfare. However, China is emerging as the fastest growing regional market given the country's position as the world's largest producer and consumer of pork. Mass vaccination programs are being carried out to control outbreaks of African swine fever.

Get more insights on veterinary vaccines market

Unlock More Insights— Explore the Report in the Language You Prefer.

French German Italian Russian Japanese Chinese Korean Portuguese

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )